Van Hout Marie Claire, Benschop Annemieke, Bujalski Michal, Dąbrowska Katarzyna, Demetrovics Zsolt, Felvinczi Katalin, Hearne Evelyn, Henriques Susana, Kaló Zsuzsa, Kamphausen Gerrit, Korf Dirk, Silva Joana Paula, Wieczorek Łukasz, Werse Bernd
1Public Health Institute, Liverpool John Moores University, Liverpool, UK.
2Bonger Institute, University of Amsterdam, Amsterdam, Netherlands.
Int J Ment Health Addict. 2018;16(2):480-495. doi: 10.1007/s11469-017-9824-1. Epub 2017 Dec 7.
Continued diversification and use of new psychoactive substances (NPS) across Europe remains a public health challenge. The study describes health and social consequences of recent NPS use as reported in a survey of marginalised, nightlife and online NPS users in the Netherlands, Hungary, Portugal, Ireland, Germany and Poland ( = 3023). Some respondents were unable to categorise NPS they had used. Use of '' and '' was most reported in Germany, Poland and Hungary, and use of '' and '' was most reported in the Netherlands. Increased heart rate and palpitation, dizziness, anxiety, horror trips and headaches were most commonly reported acute side effects. Marginalised users reported substantially more acute side effects, more mid- and long-term mental and physical problems, and more social problems. Development of country-specific NPS awareness raising initiatives, health and social service needs assessments, and targeted responses are warranted.
欧洲新型精神活性物质(NPS)持续多样化并广泛使用,这依然是一项公共卫生挑战。该研究描述了在荷兰、匈牙利、葡萄牙、爱尔兰、德国和波兰对边缘化、夜生活及在线NPS使用者进行的一项调查(n = 3023)中所报告的近期使用NPS造成的健康和社会后果。一些受访者无法对他们使用过的NPS进行分类。在德国、波兰和匈牙利,“ ”和“ ”的使用报告最多,而在荷兰,“ ”和“ ”的使用报告最多。心率加快、心悸、头晕、焦虑、恐怖体验和头痛是最常报告的急性副作用。边缘化使用者报告的急性副作用、中长期心理和身体问题以及社会问题显著更多。有必要制定针对特定国家的NPS提高认识举措、健康和社会服务需求评估以及针对性应对措施。